MedTrace Logo

Prospective Hyperthermia Database in Cancer Patients (HT Register)

NCT05993910 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2023-08-15

No results posted yet for this study

Summary

This monocentric study registry records all cancer patients at the Charité which are treated with hyperthermia to examine the therapeutic use of hyperthermia in cancer patients in the general application and to obtain an accurate risk-benefit balance

After confinement in this database are the patients prospectively in order to complications, disease status and survival status tracked.

Furthermore there is the possibility in the course of this study to an optional take part in translational accompanying research with the aim of prognostic factors for response to hyperthermia treatment.

Conditions

Interventions

OTHER

Hyperthermie Register

* die Höhe der Temperatur im Zielgebiet (42,5 bis 43 °C), * die Dauer der Anwendung und * die simultane Therapie mit Chemo- und/oder Strahlentherapie

Sponsors & Collaborators

  • Pirus Ghadjar

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-01
Primary Completion
2028-10-31
Completion
2028-10-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05993910 on ClinicalTrials.gov